|
|
|
Insider
Information: |
Brumm Joshua T |
Relationship: |
|
City: |
Pleasanton |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
746,959 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$14,899,856 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
746,959 |
|
|
Total
Value |
$14,899,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
267.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Zeltiq Aesthetics Inc |
ZLTQ |
VP of Corporate Develo... |
2012-02-17 |
7,692 |
2012-02-17 |
0 |
Premium* |
|
Aravive Inc |
ARAV |
COO and CFO |
2017-10-19 |
201,269 |
2014-04-15 |
0 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-03-11 |
537,998 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ZLTQ |
Zeltiq Aesthetics Inc |
VP of Corporate Development |
|
2012-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
7,692 |
7,692 |
0 |
- |
|
ARAV |
Aravive Inc |
Chief Financial Officer |
|
2014-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
ARAV |
Aravive Inc |
Chief Financial Officer |
|
2014-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
25,000 |
0 |
- |
|
ARAV |
Aravive Inc |
Chief Financial Officer |
|
2014-12-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,445 |
36,635 |
0 |
- |
|
ARAV |
Aravive Inc |
Chief Financial Officer |
|
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
61,548 |
0 |
- |
|
ARAV |
Aravive Inc |
Chief Financial Officer |
|
2016-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
68,835 |
0 |
- |
|
ARAV |
Aravive Inc |
COO and CFO |
|
2017-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
43,900 |
108,724 |
0 |
- |
|
ARAV |
Aravive Inc |
COO and CFO |
|
2017-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
97,000 |
202,595 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
107,027 |
107,027 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2021-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
118,190 |
213,708 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2022-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,118 |
230,902 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
144,000 |
333,123 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
358,877 |
592,556 |
0 |
- |
|
ARAV |
Aravive Inc |
COO and CFO |
|
2017-02-24 |
4 |
AS |
$20.42 |
$628,063 |
D/D |
(30,000) |
105,779 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2021-09-20 |
4 |
AS |
$15.61 |
$53,464 |
D/D |
(3,425) |
103,602 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2021-09-21 |
4 |
AS |
$16.11 |
$73,848 |
D/D |
(4,584) |
99,018 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2022-03-11 |
4 |
AS |
$8.73 |
$29,542 |
D/D |
(3,384) |
210,324 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2022-12-12 |
4 |
AS |
$10.87 |
$36,110 |
D/D |
(3,322) |
329,801 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2023-09-12 |
4 |
AS |
$10.41 |
$79,866 |
D/D |
(7,672) |
245,711 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2023-09-18 |
4 |
AS |
$9.41 |
$113,221 |
D/D |
(12,032) |
233,679 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
See Remarks |
|
2023-12-11 |
4 |
AS |
$10.72 |
$81,311 |
D/D |
(7,585) |
584,971 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
CEO & President |
|
2024-01-03 |
4 |
AS |
$18.34 |
$986,957 |
D/D |
(51,183) |
584,971 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
CEO & President |
|
2024-01-04 |
4 |
AS |
$18.40 |
$4,045,958 |
D/D |
(218,536) |
584,971 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
CEO & President |
|
2024-02-29 |
4 |
AS |
$27.50 |
$151,800 |
D/D |
(5,520) |
563,471 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
CEO & President |
|
2024-03-01 |
4 |
AS |
$28.25 |
$2,743,719 |
D/D |
(94,480) |
563,471 |
0 |
% |
|
64 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|